| Literature DB >> 35913554 |
Alec J Wozney1, Macey A Smith1, Mobeen Abdrabbo1, Cole M Birch1, Kelsey A Cicigoi1, Connor C Dolan1, Audrey E L Gerzema1, Abby Hansen1, Ethan J Henseler1, Ben LaBerge1, Caterra M Leavens1, Christine N Le1, Allison C Lindquist1, Rikaela K Ludwig1, Maggie G O'Reilly1, Jacob H Reynolds1, Brandon A Sherman1, Hunter W Sillman1, Michael A Smith1, Marissa J Snortheim1, Levi M Svaren1, Emily C Vanderpas1, Aidan Voon1, Miles J Wackett1, Moriah M Weiss1, Sanchita Hati2, Sudeep Bhattacharyya3.
Abstract
Using molecular dynamics simulations, the protein-protein interactions of the receptor-binding domain of the wild-type and seven variants of the severe acute respiratory syndrome coronavirus 2 spike protein and the peptidase domain of human angiotensin-converting enzyme 2 were investigated. These variants are alpha, beta, gamma, delta, eta, kappa, and omicron. Using 100 ns simulation data, the residue interaction networks at the protein-protein interface were identified. Also, the impact of mutations on essential protein dynamics, backbone flexibility, and interaction energy of the simulated protein-protein complexes were studied. The protein-protein interface for the wild-type, delta, and omicron variants contained several stronger interactions, while the alpha, beta, gamma, eta, and kappa variants exhibited an opposite scenario as evident from the analysis of the inter-residue interaction distances and pair-wise interaction energies. The study reveals that two distinct residue networks at the central and right contact regions forge stronger binding affinity between the protein partners. The study provides a molecular-level insight into how enhanced transmissibility and infectivity by delta and omicron variants are most likely tied to a handful of interacting residues at the binding interface, which could potentially be utilized for future antibody constructs and structure-based antiviral drug design.Entities:
Keywords: COVID-19; Delta; Molecular dynamics; Omicron; SARS-CoV-2; Spike protein
Mesh:
Substances:
Year: 2022 PMID: 35913554 PMCID: PMC9340756 DOI: 10.1007/s10930-022-10065-6
Source DB: PubMed Journal: Protein J ISSN: 1572-3887 Impact factor: 4.000
Fig. 1Site of missense mutations observed for the SARS-CoV-2 variants shown on the RBD backbone (shown in blue-colored cartoon representation). Mutation sites: green spheres represent the mutation sites found in alpha, beta, gamma, delta, eta, and kappa variants. Sites color-coded in pink are found in the omicron variant. The ACE2 is shown in red-colored cartoon representation, with a catalytically important zinc ion at its peptidase active site (Color figure online)
List of residues mutated in alpha, beta, gamma, delta, eta, and kappa variants. [31]
| Protein systems | Variant name (pango-lineage) | Missense mutations | Location |
|---|---|---|---|
| Alpha | B.1.1.7 | N501Y |
|
| Beta | B.1.351 | K417N, E484K, N501Y |
|
| Gamma | P.1 | K417T |
|
| Delta | B.1.617.2 | L452R, T478K |
|
| Eta | B.1.525 | E484K |
|
| Kappa | B.1.617.1 | L452R, E484Q |
|
Missense mutations present in the receptor-binding domain of the omicron variant. [31]
| Protein systems | Variant Name (pango-lineage) | |
|---|---|---|
| Omicron | Missense Mutations | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H |
| Location |
|
Various interaction distances between residues (in Å) observed in the three zones described in the analysis of protein–protein binding interface
| Protein systems/ zones | Inter-residue interactions | WT | Alpha | Beta | Gamma | Delta | Eta | Kappa |
|---|---|---|---|---|---|---|---|---|
| Left | Y489(OH)···F28(N) | 4.4 (0.7) | 4.6 (0.5) | 5.4 (1.2) | 4.3 (0.7) | 4.6 (0.8) | 5.3 (0.7) | 4.2 (0.5) |
| N487(ND2)···Q24(OE1) | 4.9 (1.7) | 6.5 (1.8) | 12.5 (3.8) | 4.3 (1.0) | 4.2 (1.1) | 4.4 (1.2) | 4.4 (1.2) | |
| N487(OD1)···Y83(OH) | 3.6 (1.3) | 5.1 (1.7) | 10.0 (3.3) | 2.9 (0.4) | 3.0 (0.6) | 2.8 (0.4) | 3.3(1.0) | |
| Y489(OH)···Y83(OH) | 4.2 (0.8) | 5.0 (0.6) | 5.5 (1.2) | 4.0 (0.7) | 4.0 (0.8) | 3.1 (0.6) | 4.2 (0.6) | |
| Central | K417(NZ)···D30(OD1) | 4.9 (2.1) | 4.9 (2.5) | 6.1 (1.2) | 8.7 (1.3) | 3.9 (1.0) | 8.2 (3.1) | 4.8 (1.7) |
| Y453(OH)···H34(NE2) | 3.7 (0.6) | 4.2 (0.5) | 4.5 (0.7) | 4.4 (0.9) | 4.3 (0.8) | 5.1 (0.7) | 4.0 (0.7) | |
| Q493(OE1)···K31(NZ) | 3.5 (1.0) | 4.3 (1.4) | 4.9 (1.7) | 4.1 (1.8) | 4.4 (1.7) | 5.5 (1.8) | 4.2 (1.6) | |
| Q493(NE2)···E35(OE2) | 3.9 (1.0) | 5.7 (1.3) | 4.5 (1.4) | 4.4 (1.4) | 4.2 (1.2) | 4.2 (1.0) | 4.0 (1.1) | |
| Right | Y449(OH)···Q42(NE2) | 6.4 (1.7) | 6.2 (1.7) | 9.4 (5.3) | 4.4 (1.4) | 5.7 (1.6) | 4.7 (1.5) | 5.1 (1.4) |
| Y449(OH)···D38(OD1) | 4.6 (1.6) | 3.6 (1.3) | 6.6 (5.1) | 4.6 (1.2) | 4.3 (1.4) | 4.5 (1.4) | 3.8 (1.2) | |
| Y449(OH)···K353(NZ) | 5.8 (1.4) | 9.7 (1.8) | 7.5 (4.8) | 7.5 (2.1) | 5.8 (1.1) | 5.5 (1.1) | 5.2 (0.9) | |
| Q498(OE1)···K353(NZ) | 5.3 (2.4) | 10.4 (1.7) | 8.5 (1.4) | 8.3 (2.1) | 5.4 (2.2) | 5.0 (1.9) | 4.6 (1.6) | |
| T500(OG1)···Y41(OH) | 3.4 (0.6) | 6.7 (0.9) | 4.2 (0.8) | 3.2 (0.4) | 3.2 (0.5) | 3.4 (1.0) | 3.0 (0.3) | |
| N501(ND2)···Y41(OH) | 4.9 (1.8) | 3.4 (0.5) | 5.5 (1.2) | 6.5 (1.0) | 4.0 (0.6) | 4.2 (1.2) | 3.9 (0.7) | |
| Y505(OH)···R393(NH2) | 3.6 (0.5) | 10.7 (3.1) | 8.8 (1.2) | 7.6 (1.4) | 3.6 (0.4) | 5.5 (1.9) | 4.5 (1.2) | |
| Y505(OH)···E37(OE2) | 3.3 (0.8) | 8.8 (2.1) | 7.1 (1.4) | 7.4 (1.1) | 3.2 (0.7) | 5.1 (1.7) | 4.3 (1.3) | |
| R403(NH2)···E37(OE1) | 6.1 (0.6) | 8.0 (1.2) | 7.1 (1.0) | 9.1 (1.1) | 5.9 (0.6) | 7.8 (1.5) | 8.0 (1.5) |
These distances were averaged over an ensemble of conformation collected in 100 ns MD simulation for different variants. The quantity in parenthesis represents the uncertainty in the distances
aFor these mutants, the oxygen atom of the hydroxy group of the tyrosine at 501 position has been used
bFor this mutant, the nitrogen atom of the amide group of the asparagine at 417 position has been used
cFor this mutant, the oxygen atom of the hydroxy group of the threonine at 417 position has been used
Fig. 2The key interaction networks in the delta and omicron variants that exhibited strong interactions. The ACE2 and RBD are shown in red and blue ribbons, respectively. The omicron variant has a strong interaction network (top inset panel) at the center of the long α-helix (residues 19–53), while the delta variant exhibits two stronger interaction zones (bottom inset panel), one in the central zone and the other in the right zone separated by the broken black line (Color figure online)
Interaction distances between residues (in Å) observed in the three zones of omicron variant, described in the analysis of interactions at the protein–protein binding interface
| Zones | Inter-residue interactions | Omicron |
|---|---|---|
| Left | Y489(OH)···F28(N) | 4.2 (0.5) |
| N487(ND2)···Q24(OE1) | 5.6 (1.7) | |
| N487(OD1)···Y83(OH) | 5.9 (2.5) | |
| Y489(OH)···Y83(OH) | 4.1 (0.7) | |
| Central | N417(ND2)···D30(OD1) | 9.1 (1.8) |
| Y453(OH)···H34(NE2) | 4.2 (0.8) | |
| R493(NH1)···D38(OD2) | 3.0 (0.7) | |
| R493(NH2)···D38(OD2) | 3.3 (0.5) | |
| S496 (OG1)···D38(OD1) | 3.1 (0.5) | |
| R498(NH1)···D38(OD1) | 3.1 (0.7) | |
| Right | Y449(OH)···Q42(NE2) | 6.6 (2.4) |
| Y449(OH)···D38(OD1) | 8.8 (2.6) | |
| T500(OG1)···Y41(OH) | 3.6 (0.3) | |
| Y501(OH)···Y41(OH) | 5.7 (0.6) | |
| H505(ND1)···K353(NZ) | 5.6 (0.9) | |
| R403(NH1)···E37(OE1) | 7.8 (1.0) |
These distances were averaged over an ensemble of conformation collected in 100 ns MD simulation. The quantity in parenthesis represents the uncertainty in the distances
Fig. 3Essential dynamics analysis of the wild-type and various variants, using the 100 ns simulation trajectories. The red to blue color of the backbone represents the starting and ending conformations, respectively. The extent of the backbone fluctuation is a measure of the amplitude of the motion. The higher amplitude of the dynamics correlates with the reduced binding affinity between RBD and ACE2 in these variants (Color figure online)
Decomposition of the pair-wise interaction energy between the receptor-binding domain (RBD) and the angiotensin-converting enzyme 2 (ACE2) receptor for SARS-CoV-2 variants
| Protein systems | Interaction enthalpy | Interaction entropy | Interaction gibbs free energy | |
|---|---|---|---|---|
| Wt | – 233 (4) | 0.460 (0.013) | – 371 (4) | 0 |
| Alpha | – 220 (13) | 0.486 (0.043) | – 366 (16) | 6 |
| Beta | – 172 (9) | 0.578 (0.030) | – 346 (9) | 26 |
| Gamma | – 145 (7) | 0.372 (0.023) | – 257 (7) | 115 |
| Delta | – 235 (11) | 0.546 (0.037) | – 399 (11) | –28 |
| Eta | – 207 (13) | 0.524 (0.043) | – 365 (13) | 7 |
| Kappa | – 217 (16) | 0.429 (0.053) | – 346 (16) | 26 |
| Omicron | – 380 (14) | 0.461 (0.047) | – 519 (14) | –148 |
energies were calculated using Eq. 2 for 27 °C. The uncertainties energies and entropies computed using block average method described in Sect. 2.2 are given in parenthesis
Fig. 4Interaction energies and distances for the major electrostatic interactions observed wild-type and its variants during 100 ns simulations. The * in b indicates R493-D38 interaction for the omicron variant. Uncertainties in both measurements are indicated by the error bars